Company Filing History:
1 out of 624 
1 out of 108 Years Active: 2017
Title: Chul Soo Cho: Innovator in Pharmaceutical Chemistry
Introduction
Chul Soo Cho is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing diseases associated with the activity of NFAT5, which plays a crucial role in inflammatory responses.
Latest Patents
Chul Soo Cho holds a patent for an innovative 8-oxoprotoberberine derivative or a pharmaceutically acceptable salt thereof. This patent includes a preparation method and a pharmaceutical composition aimed at preventing or treating diseases linked to NFAT5 activity. The invention demonstrates remarkable oral absorption compared to known protoberberine, making it a promising candidate for treating conditions such as rheumatoid arthritis and other inflammatory diseases. The compound has been shown to inhibit NFAT5 activity and reduce the secretion of inflammatory cytokines, providing a potential therapeutic avenue for patients suffering from these ailments.
Career Highlights
Throughout his career, Chul Soo Cho has been associated with prominent research institutions. He has worked at the Korea Research Institute of Chemical Technology, where he contributed to various projects in chemical technology. Additionally, he has been involved with The Catholic University of Korea Industry-Academic Cooperation Foundation, further bridging the gap between academic research and practical applications in the pharmaceutical industry.
Collaborations
Chul Soo Cho has collaborated with several esteemed colleagues, including Heeyeong Cho and Hee-Jong Lim. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.
Conclusion
Chul Soo Cho's innovative work in pharmaceutical chemistry highlights the importance of developing new therapeutic agents for inflammatory diseases. His contributions, particularly through his patented 8-oxoprotoberberine derivative, showcase the potential for improved treatments in the medical field.